Related Experiment Video
Updated: Jul 4, 2026

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
Published on: January 3, 2020
Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b
Pamela S Hair1, Michael D Ward, O John Semmes
1Department of Pediatrics,George L. Wright, Jr., Center for Biomedical Proteomics, Eastern Virginia Medical School, Norfolk, Virginia, USA.
Staphylococcus aureus uses clumping factor A (ClfA) to evade the human immune system. This bacterial protein binds factor I, enhancing the inactivation of complement component C3b, which hinders bacterial clearance.
Area of Science:
- Immunology
- Microbiology
- Bacterial Pathogenesis
Background:
- The human complement system is crucial for controlling Staphylococcus aureus infections.
- Previous work showed complement component C3b deposition on S. aureus leads to phagocytosis, but this can be inhibited.
- Factor I, a host complement control protein, cleaves C3b, reducing S. aureus phagocytosis.
Purpose of the Study:
- To identify specific S. aureus proteins that interact with the host complement control protein, factor I.
- To elucidate a novel mechanism by which S. aureus modifies host complement activity.
Main Methods:
- Identification of S. aureus cell wall proteins bound by factor I.
- Characterization of recombinant ClfA (rClfA) and shed ClfA fragments.
- Assays to measure factor I-mediated cleavage of C3b in the presence of rClfA and shed ClfA.
Main Results:
- Clumping factor A (ClfA), a cell wall protein of S. aureus, was identified as a specific binding protein for factor I.
- Both recombinant full-length ClfA (rClfA) and a 50-kDa shed ClfA fragment bound factor I.
- rClfA and the shed ClfA fragment significantly enhanced factor I-mediated cleavage of C3b into inactive C3b, thereby promoting immune evasion.
Conclusions:
- S. aureus employs ClfA as a mechanism to interfere with the host complement system.
- Binding of factor I by ClfA facilitates the inactivation of C3b, representing a novel immune evasion strategy for S. aureus.
Related Concept Videos
Complement System
Staphylococcal Skin Infections
Determinants of Bacterial Pathogenicity and Virulence
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Clot Retraction and Fibrinolysis
Mechanism of Antibiotic Resistance in MRSA

